文献速递乳腺妇产影像MRUS乳腺X线

妊娠及哺乳期乳腺癌筛查:实用影像策略

Breast Cancer Screening in Pregnant and Lactating Patients: A Practical Approach.
PubMed 文献 · Radiographics · 2026-01-01

本文综述妊娠及哺乳期乳腺癌筛查与诊断的影像学方法选择。妊娠期乳腺密度增高可降低钼靶敏感度,超声因无电离辐射成为症状评估首选。作者强调需权衡诊断效能与母胎安全,并讨论钼靶、超声及MRI的适用场景与禁忌。

要点

  • 妊娠及哺乳期钼靶安全,但腺体致密可掩盖恶性病变,敏感度下降。
  • 超声无电离辐射,是妊娠及哺乳期有症状患者的首选影像检查。
  • 妊娠期禁用MRI,哺乳期高危或新诊断乳腺癌患者可考虑MRI检查。

核心结论

  • 妊娠及哺乳期乳腺癌评估需个体化选择影像方法,超声是症状评估首选,钼靶安全但敏感度受腺体密度影响,妊娠期禁用MRI。

研究设计与样本

  • 本文为综述,回顾美国放射学会适宜性标准及其他专业组织指南,总结妊娠相关乳腺癌流行病学及影响影像解读的乳腺生理变化。

关键影像表现/征象

  • 妊娠及哺乳期激素变化导致乳腺实质密度增高,可遮掩恶性病变,降低钼靶敏感度。
  • MRI在哺乳期可表现为显著的背景实质强化,影响影像解读。

诊断标准与关键数值

  • 钼靶用于妊娠及哺乳期患者安全,但敏感度因腺体密度增高而可能降低。
  • 超声因无电离辐射,作为评估有症状妊娠及哺乳期患者的首要影像方法。
  • MRI在妊娠期禁用,哺乳期可用于高危或新诊断乳腺癌患者的筛查。

临床应用与阅片要点

  • 对有乳腺症状的妊娠或哺乳期患者,应优先选用超声进行评估。
  • 选择影像方法时需同时考虑诊断效能与母体及胎儿安全。
  • 对需持续筛查的高危患者,应制定个体化筛查策略并向患者和转诊医生充分沟通影像风险、获益与预期。

局限性

  • 妊娠及哺乳期人群筛查效能与结局的循证证据有限,超声在常规筛查中的作用尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Screening and diagnostic evaluation for breast cancer is increasingly common during pregnancy and lactation due to delayed childbearing and identification of elevated hereditary and familial risk during reproductive years, with patients often undergoing risk assessment beginning at 25 years of age. Although mammography is safe for pregnant and lactating patients, its sensitivity may be reduced because hormonal changes increase parenchymal density and can obscure malignant lesions. US is widely used because it does not involve exposure to ionizing radiation and serves as the primary modality for evaluating symptomatic patients. However, its role in routine screening remains uncertain because evidence regarding screening performance and outcomes in pregnant and lactating populations is limited. MRI is contraindicated during pregnancy but may be performed during lactation for screening of patients at high risk for or with newly diagnosed breast cancer, despite its pronounced background parenchymal enhancement. Timely evaluation of breast symptoms and imaging abnormalities is critical given the rising incidence of pregnancy-associated breast cancer and the potential for delayed diagnosis. Therefore, radiologists must balance diagnostic performance with maternal and fetal safety when selecting imaging modalities. The authors review the current American College of Radiology Appropriateness Criteria and the guidelines of other professional organizations; summarize the epidemiology of pregnancy-associated breast cancer and the physiologic breast changes that affect imaging interpretation; and highlight modality-specific limitations, safety considerations, and contraindications. Strategies for identifying patients at high risk for breast cancer who require continued screening and for effectively communicating imaging risks, benefits, and expectations to patients and referring clinicians are also discussed.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Fazeli, Stepenosky, Naamo, et al. Breast Cancer Screening in Pregnant and Lactating Patients: A Practical Approach. Radiographics. 2026. PMID: 42721045. doi:10.1148/rg.260005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。